The role of defensins in lung biology and therapy

American Journal of Respiratory Medicine

Volumn 1, Issue 4, 2002, Pages 249-259

  Cole, Alexander M ^a,b   Waring, Alan J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Will Rogers Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; CATHELICIDIN; DEFENSIN; GAMMA INTERFERON; ISEGANAN; PROTEGRIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CYSTIC FIBROSIS; CYTOKINE RELEASE; DRUG STRUCTURE; HUMAN; MUCOSA INFLAMMATION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RESPIRATORY EPITHELIUM; REVIEW; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION;

EID: 0037501736     PISSN: 11756365     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03256616     Document Type: Review

References (135)

1. Fleming A. On a remarkable bacteriolytic element found in tissues and secretions. Proc R Soc Lond B Biol Sci 1922; 93: 306-17
2. Harder J, Bartels J, Christophers E, et al. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001; 276 (8): 5707-13
3. Kaliner MA. Human nasal respiratory secretions and host defense. Am Rev Respir Dis 1991; 144: S52-6
4. Kaliner MA. Human nasal host defense and sinusitis. J Allergy Clin Immunol 1992; 90: 424-30
5. Cole AM, Dewan P, Ganz T. Innate antimicrobial activity of nasal secretions. Infect Immun 1999; 67 (7): 3267-75
6. Travis SM, Conway BA, Zabner J, et al. Activity of abundant antimicrobials of the human airway. Am J Respir Cell Mol Biol 1999; 20 (5): 872-9
7. Cole AM, Kim YH, Tahk S, et al. Calcitermin, a novel antimicrobial peptide isolated from human airway secretions. FEBS Lett 2001; 504 (1-2): 5-10
8. Travis SM, Singh PK, Welsh MJ. Antimicrobial peptides and proteins in the innate defense of the airway surface. Curr Opin Immunol 2001; 13 (1): 89-95
9. Boman HG. Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 1995; 13: 61-92
10. Hiemstra PS, Maassen RJ, Stolk J, et al. Antibacterial activity of anti-leukoprotease. Infect Immun 1996; 64 (11): 4520-4
11. McCray PB, Bentley L. Human airway epithelia express a β-defensin. Am J Respir Cell Mol Biol 1997; 16: 343-9
12. Singh PK, Jia HP, Wiles K, et al. Production of β-defensins by human airway epithelia. Proc Natl Acad Sci U S A 1998; 95: 14961-6
13. Ganz T, Selsted ME, Szklarek D, et al. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 1985; 76: 1427-35
14. Schnapp D, Harris A. Antibacterial peptides in bronchoalveolar lavage fluid. Am J Respir Cell Mol Biol 1998; 19 (3): 352-6
15. Bals R, Wang X, Zasloff M, et al. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A 1998; 95 (16): 9541-6
16. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir Res 2000; 1 (3): 141-50
17. Aho HJ, Grenman R, Sipila J, et al. Group II phospholipase A2 in nasal fluid, mucosa and paranasal sinuses. Acta Otolaryngol (Stockh) 1997; 117 (6): 860-3
18. Brogden KA, Ackermann M, Huttner KM. Detection of anionic antimicrobial peptides in ovine bronchoalveolar lavage fluid and respiratory epithelium. Infect Immun 1998; 66 (12): 5948-54
19. Brogden KA, Ackermann MR, McCray Jr PB, et al. Differences in the concentrations of small, anionic, antimicrobial peptides in bronchoalveolar lavage fluid and in respiratory epithelia of patients with and without cystic fibrosis. Infect Immun 1999; 67 (8): 4256-9
20. Ellison RT 3, Giehl TJ. Killing of Gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 1991; 88: 1080-91
21. Raphael GD, Jeney EV, Baraniuk JN, et al. Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions. J Clin Invest 1989; 84 (5): 1528-35
22. Samaranayake YH, Samaranayake LP, Wu PC, et al. The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans. APMIS 1997; 105 (11): 875-83
23. Singh PK, Tack BF, McCray Jr PB, et al. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol 2000; 279 (5): L799-805
24. Kalfa VC, Brogden KA. Anionic antimicrobial peptide-lysozyme interactions in innate pulmonary immunity. Int J Antimicrob Agents 1999; 13 (1): 47-51
25. Martin E, Ganz T, Lehrer RI. Defensins and other endogenous peptide antibiotics of vertebrates. J Leukoc Biol 1995; 58: 128-36
26. Lehrer RI, Bevins CL, Ganz T. Defensins and other antimicrobial peptides. In: Ogra PL, Mestecky J, Lamm ME, et al., editors. Mucosal immunology. San Diego (CA): Academic Press, 1999: 89-99
27. Ganz T. Defensins and host defense. Science 1999; 286 (5439): 420-1
28. Ouellette AJ, Bevins CL. Paneth cell defensins and innate immunity of the small bowel. Inflamm Bowel Dis 2001; 7 (1): 43-50
29. Hughes AL. Evolutionary diversification of the mammalian defensins. Cell Mol Life Sci 1999: 56 (1-2): 94-103
30. Ganz T. Defensins in the urinary tract and other tissues. J Infect Dis 2001; 183 Suppl. 1: S41-2
31. Lehrer RI, Ganz T. Defensins of vertebrate animals. Curr Opin Immunol 2002; 14 (1): 96-102
32. Agerberth B, Charo J, Werr J, et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000; 96 (9): 3086-93
33. Daher KA, Lehrer RI, Ganz T, et al. Isolation and characterization of human defensin cDNA clones. Proc Natl Acad Sci U S A 1988; 85: 7327-31
34. Selsted ME, Harwig SS, Ganz T, et al. Primary structures of three human neutrophil defensins. J Clin Invest 1985; 76: 1436-9
35. Wilde CG, Griffith JE, Marra MN, et al. Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family. J Biol Chem 1989; 264: 11200-3
36. Jones DE, Bevins CL. Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 1992; 267: 23216-25
37. Jones DE, Bevins CL. Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett 1993; 315: 187-92
38. Porter EM, Liu L, Oren A, et al, Localization of human intestinal defensin 5 in Paneth cell granules. Infect Immun 1997; 65: 2389-95
39. Porter EM, vanDam E, Valore EV, et al. Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect Immun 1997; 65: 2396-401
40. O'Neil DA, Porter EM, Elewaut D, et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999; 163 (12): 6718-24
41. Mathews M, Jia HP, Guthmiller JM, et al. Production of β-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun 1999; 67 (6): 2740-5
42. Goldman M, Anderson G, Stolzenberg ED, et al. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997; 88: 553-60
43. Valore EV, Park CH, Quayle AJ, et al. Human β-defensin-1: An antimicrobial peptide of urogenital tissues. J Clin Invest 1998; 101 (8): 1633-42
44. Schnapp D, Reid CJ, Harris A. Localization of expression of human β-defensin-1 in the pancreas and kidney. J Pathol 1998; 186 (1): 99-103
45. Bensch KW, Raida M, Magert HJ, et al. hBD-1: a novel beta-defensin from human plasma. FEBS Lett 1995; 368: 331-5
46. Zhao CQ, Wang I, Lehrer RI. Widespread expression of β-defensin HBD-1 in human secretory glands and epithelial cells. FEBS Lett 1996; 396: 319-22
47. Tunzi CR, Harper PA, Bar-Oz B, et al. Beta-defensin expression in human mammary gland epithelia. Pediatr Res 2000; 48 (1): 30-5
48. Jia HP, Starner T, Ackermann M, et al. Abundant human beta-defensin-1 expression in milk and mammary gland epithelium. J Pediatr 2001; 138 (1): 109-12
49. Harder J, Bartels J, Christophers E, et al. A peptide antibiotic from human skin. Nature 1997; 387: 861-2
50. Schroder JM, Harder J. Human β-defensin-2. Int J Biochem Cell Biol 1999; 31 (6): 645-51
51. Harder J, Siebert R, Zhang Y, et al. Mapping of the gene encoding human β-defensin-2 (DEFB2) to chromosome region 8p22-p23. 1. Genomics 1997; 46 (3): 472-5
52. Garcia JR, Jaumann F, Schulz S, et al. Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res 2001; 306 (2): 257-64
53. Garcia JR, Krause A, Schulz S, et al. Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 2001; 15 (10): 1819-21
54. Daher KA, Selsted ME, Lehrer RI. Direct inactivation of viruses by human granulocyte defensins. J Virol 1986; 60: 1068-74
55. Lehrer RI, Barton A, Daher KA, et al. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest 1989; 84: 553-61
56. Miyasaki KT, Bodeau AL, Ganz T, et al. In vitro sensitivity of oral, Gram-negative, facultative bacteria to the bactericidal activity of human neutrophil defensins. Infect Immun 1990; 58: 3934-40
57. Ogata K, Linzer BA, Zuberi RI, et al. Activity of defensins from human neutrophilic granulocytes against Mycobacterium avium-Mycobacterium intracellulare. Infect Immun 1992; 60: 4720-5
58. Ganz T, Lehrer RI. Antimicrobial peptides of leukocytes. Curr Opin Hematol 1997; 4: 53-8
59. Huttner KM, Bevins CL. Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res 1999; 45 (6): 785-94
60. Hill CP, Yee J, Selsted ME, et al. Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 1991; 251: 1481-5
61. Sawai MV, Jia HP, Liu L, et al. The NMR structure of human beta-defensin-2 reveals a novel alpha-helical segment. Biochemistry 2001; 40 (13): 3810-6
62. Hoover DM, Chertov O, Lubkowski J. The structure of human beta-defensin-1: new insights into structural properties of beta-defensins. J Biol Chem 2001; 276 (42): 39021-6
63. Hoover DM, Rajashankar KR, Blumenthal R, et al. The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J Biol Chem 2000; 275 (42): 32911-8
64. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415 (6870): 389-95
65. Gunn JS, Miller SI. PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J Bacteriol 1996; 178: 6857-64
66. Gunn JS, Ryan SS, Van Velkinburgh JC, et al. Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar typhimurium. Infect Immun 2000; 68 (11): 6139-46
67. Peschel A, Jack RW, Otto M, et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with 1-lysine. J Exp Med 2001; 193 (9): 1067-76
68. Harder J, Meyer-Hoffert U, Teran LM, et al. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol 2000; 22 (6): 714-21
69. Samaranayake LP, Tobgi RS, MacFarlane TW. Anti-candida activity of murine bronchoalveolar lavage fluid. J Med Microbiol 1994; 40 (5): 350-7
70. Schroder JM, Harder J. Human β-defensin-2. Int J Biochem Cell Biol 1999; 31 (6): 645-51
71. Liu AY, Destoumieux D, Wong AV, et al. Human β-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. Invest Dermatol 2002; 118 (2): 275-81
72. Cole AM, Tahk S, Oren A, et al. Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol 2001; 8 (6): 1064-9
73. Territo MC, Ganz T, Selsted ME, et al. Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest 1989; 84: 2017-20
74. Chertov O, Michiel DF, Xu L, et al. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8- stimulated neutrophils. J Biol Chem 1996; 271: 2935-40
75. Yang D, Chertov O, Bykovskaia SN, et al. β-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999; 286 (5439): 525-8
76. Yang D, Chen Q, Chertov O, et al. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol 2000; 68 (1): 9-14
77. Yang D, Chertov O, Bykovskaia SN, et al. β-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999; 286 (5439): 525-8
78. Perez-Canadillas JM, Zaballos A, Gutierrez J, et al. NMR solution structure of murine CCL20/MIP-3alpha, a chemokine that specifically chemoattracts immature dendritic cells and lymphocytes through its highly specific interaction with the beta-chemokine receptor CCR6. J Biol Chem 2001; 276 (30): 28372-9
79. - CXC chemokines display defensin-like antimicrobial activity. J Immunol 2001; 167 (2): 623-7
80. Sauty A, Dziejman M, Taha RA, et al. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol 1999; 162 (6): 3549-58
81. Lauw FN, Simpson AJ, Prins JM, et al. The CXC chemokines gamma interferon (IFN-γ)-inducible protein 10 and monokine induced by IFN-γ are released during severe melioidosis. Infect Immun 2000; 68 (7): 3888-93
82. Billiau A, Vandenbroeck K. IFN-γ. In: Oppenheim JJ, Feldmann M, Duram SK, et al., editors. Cytokine reference: a compendium of cytokines and other mediators of host defense. New York (NY): Academic Press, 2000: 641-88
83. Zhu QZ, Singh AV, Bateman A, et al. The corticostatic (anti-ACTH) and cytotoxic activity of peptides isolated from fetal, adult and tumor-bearing lung. J Steroid Biochem 1987; 27: 1017-22
84. Higazi AA, Barghouti II, Abu-Much R. Identification of an inhibitor of tissue-type plasminogen activator-mediated fibrinolysis in human neutrophils: a role for defensin. J Biol Chem 1995; 270: 9472-7
85. Higazi AAR, Ganz T, Kariko K, et al. Defensin modulates tissue-type plasminogen activator and plasminogen binding to fibrin and endothelial cells. J Biol Chem 1996; 271: 17650-5
86. Andreu D, Rivas L. Animal antimicrobial peptides: an overview. Biopolymers 1998; 47 (6): 415-33
87. Gudmundsson GH, Agerberth B. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. J Immunol Methods 1999; 232 (1-2): 45-54
88. Panyutich AV, Hiemstra PS, Van Wetering S, et al. Human neutrophil defensin and serpins form complexes and inactivate each other. Am J Respir Cell Mol Biol 1995; 12: 351-7
89. Panyutich A, Ganz T. Activated alpha 2-macroglobulin is a principal defensin-binding protein. Am J Respir Cell Mol Biol 1991; 5: 101-6
90. Panyutich AV, Szold O, Poon PH, et al. Identification of defensin binding to C1 complement. FEBS Lett 1994; 356: 169-73
91. Murphy CJ, Foster BA, Mannis MJ, et al. Defensins are mitogenic for epithelial cells and fibroblasts. J Cell Physiol 1993; 155: 408-13
92. Hiratsuka T, Nakazato M, Date Y, et al. Identification of human beta-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia. Biochem Biophys Res Commun 1998; 249 (3): 943-7
93. Ortega MR, Ganz T, Milner SM. Human beta defensin is absent in burn blister fluid. Burns 2000; 26 (8): 724-6
94. Milner SM, Ortega MR. Reduced antimicrobial peptide expression in human burn wounds. Burns 1999; 25 (5): 411-3
95. Gregory RJ, Cheng SH, Rich DP, et al. Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature 1990; 347 (6291): 382-6
96. Smith JJ, Travis SM, Greenberg EP, et al. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996; 85: 229-36
97. Knowles MR, Robinson JM, Wood RE, et al. Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects. J Clin Invest 1997; 100 (10): 2588-95
98. Matsui H, Grubb BR, Tarran R, et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998; 95 (7): 1005-15
99. Ganz T, Metcalf JA, Gallin JI, et al. Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and 'specific' granule deficiency. J Clin Invest 1988; 82: 552-6
100. Lomax KJ, Gallin JI, Rotrosen D, et al. Selective defect in myeloid cell lactoferrin gene expression in neutrophil specific granule deficiency. J Clin Invest 1999; 83: 514-9
101. Raphael GD, Davis JL, Fox PC, et al. Glandular secretion of lactoferrin in a patient with neutrophil lactoferrin deficiency. J Allergy Clin Immunol 1989; 84 (6 Pt 1): 914-9
102. Revenis ME, Kaliner MA. Lactoferrin and lysozyme deficiency in airway secretions: association with the development of bronchopulmonary dysplasia. J Pediatr 1992; 121: 262-70
103. Islam D, Bandholtz L, Nilsson J, et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 2001; 7 (2): 180-5
104. Nizet V, Ohtake T, Lauth X, et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001; 414 (6862): 454-7
105. Pestonjamasp VK, Huttner KH, Gallo RL. Processing site and gene structure for the murine antimicrobial peptide CRAMP. Peptides 2001; 22 (10): 1643-50
106. Zanetti M, Litteri L, Gennaro R, et al. Bactenecins, defense polypeptides of bovine neutrophils, are generated from precursor molecules stored in the large granules. J Cell Biol 1990; 111: 1363-71
107. Zanetti M, Litteri L, Griffiths G, et al. Stimulus-induced maturation of probactenecins, precursors of neutrophil antimicrobial polypeptides. J Immunol 1991; 146: 4295-300
108. Scocchi M, Skerlavaj B, Romeo D, et al. Proteolytic cleavage by neutrophil elastase converts inactive storage proforms to antibacterial bactenecins. Eur J Biochem 1992; 209: 589-95
109. Panyutich A, Shi J, Boutz PL, et al. Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins. Infect Immun 1997; 65: 978-85
110. Shi J, Ganz T. The role of protegrins and other elastase-activated polypeptides in the bactericidal properties of porcine inflammatory fluids. Infect Immun 1998; 66 (8): 3611-7
111. Sorensen OE, Follin P, Johnsen AH, et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001; 97 (12): 3951-9
112. Agerberth B, Lee JY, Bergman T, et al. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem 1991; 202: 849-54
113. Kokryakov VN, Harwig SS, Panyutich EA, et al. Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett 1993; 327: 231-6
114. Storici P, Zanetti M. A cDNA derived from pig bone marrow cells predicts a sequence identical to the intestinal antibacterial peptide PR-39. Biochem Biophys Res Common 1993; 196: 1058-65
115. Storici P, Zanetti M. A novel cDNA sequence encoding a pig leukocyte antimicrobial peptide with a cathelin-like pro-sequence. Biochem Biophys Res Commun 1993; 196: 1363-8
116. Zhao C, Liu L, Lehrer RI. Identification of a new member of the protegrin family by cDNA cloning. FEBS Lett 1994; 346: 285-8
117. Harwig SS, Kokryakov VN, Swiderek KM, et al. Prophenin-1, an exceptionally proline-rich antimicrobial peptide from porcine leukocytes. FEBS Lett 1995; 362: 65-9
118. Strukelj B, Pungercar J, Kopitar G, et al. Molecular cloning and identification of a novel porcine cathelin- like antibacterial peptide precursor. Biol Chem Hoppe Seyler 1995; 376: 507-10
119. Tossi A, Scocchi M, Zanetti M, et al. PMAP-37, a novel antibacterial peptide from pig myeloid cells. cDNA cloning, chemical synthesis and activity. Eur J Biochem 1995; 228: 941-6
120. Cole AM, Shi J, Ceccarelli A, et al. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood 2001; 97 (1): 297-304
121. Wilson CL, Ouellette AJ, Satchell DP, et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999; 286 (5437): 113-7
122. Dunsmore SE, Saarialho-Kere UK, Roby JD, et al. Matrilysin expression and function in airway epithelium. J Clin Invest 1998; 102 (7): 1321-31
123. Akinbi HT, Epaud R, Bhatt H, et al. Bacterial killing is enhanced by expression of lysozyme in the lungs of transgenic mice. J Immunol 2000; 165 (10): 5760-6
124. Hancock RE. Peptide antibiotics. Lancet 1997; 349 (9049): 418-22
125. Hancock RE. Host defence (cationic) peptides: what is their future clinical potential? Drugs 1999; 57 (4): 469-73
126. Tam JP, Xu J, Eom KD. Methods and strategies of peptide ligation. Biopolymers 2001; 60 (3): 194-205
127. Porter EM, Liu L, Oren A, et al. Localization of human intestinal defensin 5 in Paneth cell granules. Infect Immun 1997; 65: 2389-95
128. Valore EV, Park CH, Quayle AJ, et al. Human β-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 1998; 101 (8): 1633-42
129. Fahrner RL, Dieckmann T, Harwig SS, et al. Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. Chem Biol 1996; 3: 543-50
130. Trabi M, Schirra HJ, Craik DJ. Three-dimensional structure of RTD-1, a cyclic antimicrobial defensin from Rhesus macaque leukocytes. Biochemistry 2001; 40 (14): 4211-21
131. Heller WT, Waring AJ, Lehrer RI, et al. Membrane thinning effect of the beta-sheet antimicrobial protegrin. Biochemistry 2000; 39 (1): 139-45
132. Roumestand C, Louis V, Aumelas A, et al. Oligomerization of protegrin-1 in the presence of DPC micelles: a proton high-resolution NMR study. FEBS Lett 1998; 421 (3): 263-7
133. Tang YQ, Yuan J, Osapay G, et al. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated α-defensins. Science 1999; 286 (5439): 498-502
134. Leonova L, Kokryakov VN, Aleshina GM, et al. Circular minidefensins and posttranslational generation of molecular diversity. J Leukoc Biol 2001; 70 (3): 461-4
135. Cole AM, Hong T, Boo LM, et al. Retrocyclin: a primate peptide that protects cells from infectino by T- and M-tropic strains of HIV-1. Proc Natl Acad Sci U S A 2002; 99 (4): 1813-8